Dr. Barlogie is Director of the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas. He also is Madge Simmons Professor of Cancer Research.
Dr. Barlogie received his medical degree from Heidelberg University, Germany, and his research degree from the Max Planck Institute for Medical Research, also in Heidelberg. He continued his postgraduate clinical training at the University of Munich, The University of Münster, and the M.D. Anderson Hospital and Tumor Institute in Houston, Texas.
Dr. Barlogie held numerous professional appointments at M.D. Anderson Hospital and Tumor Institute, the University of Texas Medical School at Houston, and the University of Texas at Houston. In addition to his current appointments at the University of Arkansas, he still holds an Adjunct Professor of Medicine (Hematology) position at M.D. Anderson Hospital and Tumor Institute.
Not only is Dr. Barlogie a prolific author; having written or contributed to several hundred journal articles, abstracts, and book chapters, he is also a noted presenter in the fields of hematology and oncology. Dr. Barlogie holds/has held editorial board positions on the following journals: Cell and Tissue Kinetics, Cytometry , Clinical Cancer Research, Annals of Hematology and Blood.